HSE approves use of Spinraza drug
The HSE has today approved the use of the new drug Spinraza.
The medication is used mostly by children with Spinal Muscular Atrophy (SMA).
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.




